BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Up 156.1% in February

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 10,500 shares, an increase of 156.1% from the January 31st total of 4,100 shares. Based on an average daily volume of 32,100 shares, the short-interest ratio is presently 0.3 days.

BioNxt Solutions Stock Performance

BioNxt Solutions stock remained flat at $0.35 during mid-day trading on Friday. The company’s stock had a trading volume of 15 shares, compared to its average volume of 10,361. The stock has a market capitalization of $39.66 million, a price-to-earnings ratio of -8.74 and a beta of 0.69. BioNxt Solutions has a 52 week low of $0.11 and a 52 week high of $0.49. The stock has a fifty day moving average price of $0.29 and a 200-day moving average price of $0.22.

BioNxt Solutions (OTCMKTS:BNXTF) last announced its quarterly earnings results on Friday, November 29th. The company reported ($0.01) EPS for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.